Neill J Liptrott (Neill Liptrott)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

International journal of molecular sciences

Journal of materials chemistry. B

Cell & bioscience

Clinical pharmacology and therapeutics

University of Liverpool

University of Liverpool (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Liverpool Jul 10 2018

United Kingdom

Lecturer :: Pharmacology and Therapeutics

University of Liverpool - Jul 10 2018

United Kingdom

Tenure track fellow :: Molecular and clinical pharmacology

University of Liverpool

United Kingdom

Senior postdoctoral research associate :: Molecular and clinical pharmacology

University of Liverpool

United Kingdom

Postdoctoral research associate :: Molecular and Clinical Pharmacology

Royal Liverpool and Broadgreen University Hospitals NHS Trust

United Kingdom

Postdoctoral research associate :: National Biomedical Research Centre for Microbial Disease

Royal Liverpool and Broadgreen University Hospitals NHS Trust

United Kingdom

Research assistant :: Biomedical Research Centre for Microbial Disease

Education History

University of Liverpool

United Kingdom

PHD

University of Liverpool

United Kingdom

MSC

University of Liverpool

United Kingdom

BSC

Publications

Christopher A W David, Jolanda P Vermeulen, Sabrina Gioria, Rob J Vandebriel, Neill J Liptrott
Nano(bio)Materials Do Not Affect Macrophage Phenotype-A Study Conducted by the REFINE Project. International journal of molecular sciences 25 (10) (2024)
Christopher A W David, Jolanda P Vermeulen, Sabrina Gioria, Rob J Vandebriel, Neill J Liptrott
Nano(bio)Materials Do Not Affect Macrophage Phenotype-A Study Conducted by the REFINE Project. International journal of molecular sciences 25 (10) (2024)
Alejandra Hernandez Pichardo, Bettina Wilm, Neill J Liptrott, Patricia Murray
Intravenous Administration of Human Umbilical Cord Mesenchymal Stromal Cells Leads to an Inflammatory Response in the Lung. Stem cells international 2023 (2023)
Chung Liu, Faye Y Hern, Anika Shakil, Kartik Temburnikar, Pierre Chambon, Neill J Liptrott, Tom O McDonald, Megan Neary, Charles Flexner, Andrew Owen, Caren Freel Meyers, Steven P Rannard
Polymer-prodrug conjugates as candidates for degradable, long-acting implants, releasing the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine. Journal of materials chemistry. B (2023)
Alexander J Plant-Hately, Burcu Eryilmaz, Christopher A W David, Danielle E Brain, Bethany J Heaton, Yvonne Perrie, Neill J Liptrott
Exposure of the Basophilic Cell Line KU812 to Liposomes Reveals Activation Profiles Associated with Potential Anaphylactic Responses Linked to Physico-Chemical Characteristics. Pharmaceutics 14 (11) (2022)
Anika Shakil, Faye Y Hern, Chung Liu, Kartik Temburnikar, Pierre Chambon, Neill J Liptrott, Tom O McDonald, Megan Neary, Andrew Owen, Caren Freel Meyers, Steven P Rannard
Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants. Journal of materials chemistry. B 10 (23) (2022)
Yelixza I Avila, Morgan Chandler, Edward Cedrone, Hannah S Newton, Melina Richardson, Jie Xu, Jeffrey D Clogston, Neill J Liptrott, Kirill A Afonin, Marina A Dobrovolskaia
Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier. Molecules (Basel, Switzerland) 26 (3) (2021)
Christopher A W David, M Estela Del Castillo Busto, Susana Cuello-Nuñez, Heidi Goenaga-Infante, Michael Barrow, David G Fernig, Patricia Murray, Matthew J Rosseinsky, Andrew Owen, Neill J Liptrott
Assessment of changes in autophagic vesicles in human immune cell lines exposed to nano particles. Cell & bioscience 11 (1) (2021)
Francesco Amadeo, Antonius Plagge, Anitta Chacko, Bettina Wilm, Vivien Hanson, Neill J Liptrott, Patricia Murray, Arthur Taylor
Firefly luciferase offers superior performance to AkaLuc for tracking the fate of administered cell therapies. European journal of nuclear medicine and molecular imaging (2021)
Usman Arshad, Henry Pertinez, Helen Box, Lee Tatham, Rajith K R Rajoli, Paul Curley, Megan Neary, Joanne Sharp, Neill J Liptrott, Anthony Valentijn, Christopher A W David, Steven P Rannard, Paul M O'Neill, Ghaith Aljayyoussi, Shaun H Pennington, Stephen A Ward, Andrew Hill, David J Back, Saye H Khoo, Patrick G Bray, Giancarlo A Biagini, Andrew Owen
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics. Clinical pharmacology and therapeutics 108 (4) (2020)
Rajith Kumar Reddy Rajoli, Henry Pertinez, Usman Arshad, Helen Box, Lee Tatham, Paul Curley, Megan Neary, Joanne Sharp, Neill J Liptrott, Anthony Valentijn, Christopher David, Steven P Rannard, Ghaith Aljayyoussi, Shaun H Pennington, Andrew Hill, Marta Boffito, Stephen A Ward, Saye H Khoo, Patrick G Bray, Paul M O'Neill, W Dave Hong, Giancarlo A Biagini, Andrew Owen
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. medRxiv : the preprint server for health sciences (2020)
Rajith Kumar Reddy Rajoli, Henry Pertinez, Usman Arshad, Helen Box, Lee Tatham, Paul Curley, Megan Neary, Joanne Sharp, Neill J Liptrott, Anthony Valentijn, Christopher A W David, Steven P Rannard, Ghaith Aljayyoussi, Shaun H Pennington, Azmil H Abdul-Rahim, Marta Boffito, Stephen A Ward, Saye H Khoo, Patrick G Bray, Paul M O'Neill, W David Hong, Giancarlo A Biagini, Andrew Owen
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. British journal of clinical pharmacology 87 (4) (2020)

Neill J Liptrott.css-eqlu8i{font-size:small;padding-left:4px;} (Neill Liptrott)

Publication Activity (10 Years)

Top Topics

Top Venues

Neill J Liptrott (Neill Liptrott)